Eric Young is swapping the ring for hosting duties, as he prepares to host the newest series on AXS TV. The TNA star is ...

Axis Capital (AXS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application (NDA) for AXS-07 for the acute treatment of migraine. AXS-07 is an oral agent that consist ...

Investors with an interest in Insurance - Property and Casualty stocks have likely encountered both Axis Capital (AXS) and Selective Insurance (SIGI). But which of these two companies is the best ...

FDA sets PDUFA action goal date of January 31, 2025NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: AXSM), a ...

Stand-up comedy at Drai’s After Hours, Pink at Allegiant Stadium, the annual AFAN Black & White Party at the Palms and more ...

AXS FTSE Vntr Cptl RetTrckr Fd earns a Below Average Process Pillar rating. The process benefits from tracking an index. Historical data, like Morningstar's Active/Passive Barometer, finds that ...

Axsome Therapeutics, Inc. (AXSM) announced on Wednesday that the FDA has accepted the resubmission of its New Drug Application or ...

Discover what crypto is and how it works. A cryptocurrency is a digital form of money. They are digital assets created to be used to pay for goods and services. Cryptocurrencies can be used as a ...

4, 5 About AXS-07 AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic investigational medicine for the acute treatment of migraine, consisting of MoSEIC™ meloxicam and rizatriptan.